Seshadri Neervannan Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

Seshadri Neervannan is Chief Operating Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 79,183 shares of TARS, which is worth approximately $5.72 Million. The most recent transaction as insider was on Dec 16, 2025, when has been sold 950 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.2K

0.63% 3M change

22.26% 12M change

Total Value Held $5.72 Million

Seshadri Neervannan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 16 2025	SELL Bona fide gift	-	950 Reduced 1.19%	79,183 Common Stock
Mar 20 2025	SELL Open market or private sale	$122,017 $50.11 p/Share	2,435 Reduced 2.97%	79,682 Common Stock
Mar 19 2025	SELL Open market or private sale	$120,538 $47.4 p/Share	2,543 Reduced 3.0%	82,117 Common Stock
Mar 18 2025	SELL Open market or private sale	$120,585 $46.29 p/Share	2,605 Reduced 2.99%	84,660 Common Stock
Mar 15 2025	BUY Exercise of conversion of derivative security	-	21,264 Added 19.59%	87,265 Common Stock
Mar 18 2024	SELL Open market or private sale	$149,297 $30.6 p/Share	4,879 Reduced 7.01%	64,767 Common Stock
Mar 15 2024	BUY Exercise of conversion of derivative security	-	13,245 Added 15.98%	69,646 Common Stock

Mar 23 2023	SELL Open market or private sale	$4,738 $12.15 p/Share	390 Reduced 0.71%	54,696 Common Stock
Mar 22 2023	SELL Open market or private sale	$4,790 $12.64 p/Share	379 Reduced 0.68%	55,086 Common Stock
Mar 21 2023	SELL Open market or private sale	$4,795 $12.89 p/Share	372 Reduced 0.67%	55,465 Common Stock
Mar 20 2023	SELL Open market or private sale	$4,791 $12.61 p/Share	380 Reduced 0.68%	55,837 Common Stock
Mar 17 2023	SELL Open market or private sale	$4,780 $13.28 p/Share	360 Reduced 0.64%	56,217 Common Stock
Mar 16 2023	SELL Open market or private sale	$4,794 $13.43 p/Share	357 Reduced 0.63%	56,577 Common Stock
Mar 15 2023	BUY Exercise of conversion of derivative security	-	5,097 Added 8.22%	56,934 Common Stock

Seshadri Neervannan

Chief Operating Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Value

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS

Account